Does CareFirst BlueCross BlueShield Cover Prolia?
The verdict
Covered on most plans
CareFirst BlueCross BlueShield, the independent BCBS licensee serving Maryland, DC, and Northern Virginia, covers Prolia under the medical benefit with prior authorization. Prolia is administered in a clinician's office every 6 months and billed under HCPCS J0897 per LCD L33394 — it is not a pharmacy-counter drug for most CareFirst Medicare members. Like other BCBS licensees, CareFirst is moving toward Jubbonti biosimilar preference as of 2025. Always verify under CareFirst's own medical policy, not a national BCBS summary.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with CareFirst BlueCross BlueShield using your member ID.
Key facts
CareFirst is an independent BCBS licensee serving MD, DC, and Northern Virginia — it publishes its own Prolia medical policy, separate from any national Blue Cross summary.
CareFirst BlueCross BlueShield medical policy library, carefirst.com
Prolia is most often a Part B buy-and-bill drug billed under HCPCS J0897 — not a Part D pharmacy pickup. The $2,100 Part D out-of-pocket cap does not apply to the Part B pathway.
CMS Local Coverage Determination L33394; Medicare.gov
Multiple BCBS licensees adopted the interchangeable Jubbonti biosimilar as the preferred denosumab product in 2025 (Independence Blue Cross Sept. 1; Blue Shield CA step therapy). CareFirst is tracking this trend.
Independence Blue Cross formulary announcement; Blue Shield of California drug policy
Medicare vs. commercial coverage
Whether CareFirst BlueCross BlueShield covers Prolia depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage / Medicare supplement (Part B medical benefit): Prolia is covered as a clinician-administered subcutaneous injection every 6 months, billed under HCPCS J0897 incident to a physician service per LCD L33394. CareFirst Medicare supplement (Medigap) members on Original Medicare pay 20% Part B coinsurance after the Part B deductible; a Medigap plan typically covers that 20%, reducing out-of-pocket to $0. CareFirst Medicare Advantage plans may require prior authorization with documentation of osteoporosis and high fracture risk, and may apply step therapy toward the Jubbonti (denosumab-bddz) biosimilar in line with the broader BCBS federation move. The $2,100 Part D out-of-pocket cap does NOT apply to Part B drugs. Verify under CareFirst's specific Medicare plan benefits.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: CareFirst commercial and employer-group plans cover Prolia under the medical benefit with prior authorization per CareFirst's own medical policy. Documentation of osteoporosis with high fracture risk (T-score at or below -2.5, prior fragility fracture, or high FRAX score) is required. PA approval is typically 12 months. Biosimilar preference for Jubbonti is emerging in line with the broader BCBS federation trend. ACA/Individual: covered with PA for eligible members on CareFirst Marketplace plans in Maryland, DC, and Northern Virginia. Medicaid: CareFirst Community Health Plan (serving DC and Maryland Medicaid) covers Prolia for osteoporosis with high fracture risk per state PDL at nominal cost-share with PA. Not covered outside FDA-approved osteoporosis and bone-loss indications.
The 3 boxes you must tick to get approved
Commercial plans that will consider Prolia require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Prolia actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,786–$2,507 per 60 mg dose without insurance (estimates: Medicare.org ~$1,786; GoodRx ~$2,507). Actual cash price varies by site of care.
List price with no coverage — before any manufacturer savings card.
With coverage
Original Medicare plus CareFirst Medigap supplement: 20% Part B coinsurance after the Part B deductible; Medigap typically covers the 20%, reducing out-of-pocket to $0. CareFirst Medicare Advantage: observed MA plan copays across BCBS plans range $0–$500 per injection — verify on your specific CareFirst plan documents. Commercial/Employer: medical-benefit coinsurance per CareFirst plan design. Medicaid: nominal cost-share per state PDL.
Typical monthly copay once prior authorization is approved.
Bridge program
Amgen offers copay support for Prolia for commercially insured patients. This program is NOT available to Medicare or Medicaid beneficiaries under federal anti-kickback rules.
Reduced copay through the assistance program, where eligible.
All figures are estimates. The Part D $2,100 out-of-pocket cap does NOT apply to the Part B medical pathway. Verify your specific cost-share on CareFirst member portal or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Go to CareFirst's medical policy library and search for denosumab or Prolia
CareFirst maintains its own medical policies independent of other BCBS licensees. Visit carefirst.com and navigate to the medical policies section. Search for 'denosumab,' 'Prolia,' or HCPCS code J0897. This will show you the current PA criteria and any biosimilar requirements specific to CareFirst — not a generic national Blue Cross policy.
- 2
Ask your prescriber which denosumab product (Prolia or Jubbonti) CareFirst covers
CareFirst is moving in the direction of Jubbonti (denosumab-bddz) biosimilar preference, consistent with Independence Blue Cross and other BCBS plans. Your prescribing clinician can check whether CareFirst currently authorizes Prolia directly or requires step therapy through Jubbonti first. Jubbonti contains the same denosumab molecule and is administered identically — an in-office subcutaneous injection every 6 months.
- 3
Confirm your benefit routing: Part B medical benefit or Part D pharmacy
For most CareFirst Medicare members, Prolia is a Part B medical-benefit drug — not a Part D pharmacy pickup. Verify this under your Part B benefits in your CareFirst plan summary. If you have a CareFirst Medigap supplement, the 20% Part B coinsurance is typically covered by your supplement. Call CareFirst member services at the number on your ID card for a cost estimate specific to your plan and site of care.
Options if CareFirst BlueCross BlueShield won't cover Prolia
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Jubbonti (denosumab-bddz)
The FDA-approved interchangeable biosimilar for Prolia, same 60 mg denosumab molecule administered by a clinician every 6 months. CareFirst and other BCBS licensees are moving toward Jubbonti as the preferred denosumab product. Existing Prolia authorizations typically transition automatically when a plan adopts the biosimilar.
Fosamax (alendronate) — generic bisphosphonate
Oral generic bisphosphonate, Tier 1 on most formularies. Common first-line osteoporosis treatment. Some plans consider prior bisphosphonate use when evaluating a Prolia or Jubbonti PA request.
Reclast (zoledronic acid)
Annual IV bisphosphonate infusion administered in a clinic and billed under the medical benefit. Typically covered at lower cost-share than Prolia. May be appropriate for patients unable to tolerate oral bisphosphonates.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. CareFirst BlueCross BlueShield is an independent BCBS licensee serving Maryland, DC, and Northern Virginia with its own medical policies. National BCBS summaries do not reflect CareFirst's specific PA criteria, biosimilar requirements, or cost-share rules. Always look up Prolia or denosumab directly on CareFirst's medical policy pages at carefirst.com rather than relying on a generic Blue Cross summary.
CareFirst is moving toward the Jubbonti (denosumab-bddz) biosimilar in line with Independence Blue Cross and other BCBS licensees, which adopted Jubbonti as their preferred denosumab product effective September 1, 2025. Whether CareFirst currently requires Jubbonti as a step before branded Prolia depends on your specific plan and its most recent medical policy update — confirm with your prescribing clinician or CareFirst medical management.
On Original Medicare with a CareFirst Medigap supplement, your cost is typically the 20% Part B coinsurance after the Part B deductible; the Medigap plan usually covers this 20%, making your cost $0. On a CareFirst Medicare Advantage plan, observed copays across BCBS Medicare plans range $0–$500 per injection — verify your specific plan cost-share with CareFirst member services. Commercial members should check their plan's medical-benefit coinsurance schedule.
No. For most CareFirst Medicare members, Prolia is a Part B medical-benefit drug billed in the clinic under HCPCS J0897 — not a Part D pharmacy drug. The $2,100 Part D out-of-pocket cap (2026) applies only to Part D drugs. Part B cost-sharing is governed by your 20% coinsurance and whatever supplement or MA plan you have. Medigap plans typically cover the Part B 20%, making out-of-pocket cost $0.
Related Articles
Does CareFirst BlueCross BlueShield Cover Mounjaro? 2026 | Curex
CareFirst BlueCross BlueShield (MD/DC/VA) covers Mounjaro for type 2 diabetes with prior authorization — not weight loss. Medicaid state-dependent.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreDoes CareFirst BCBS Cover Wegovy? 2026 Guide | Curex
CareFirst BCBS covers Wegovy on large-group plans (Tier 2/4, PA required) but excludes it on ACA Exchange plans. 2026 criteria explained.
Read moreDoes CareFirst BlueCross BlueShield Cover Ozempic? 2026 | Curex
CareFirst covers Ozempic for type 2 diabetes with prior auth — not weight loss. FEHB T2D enrollees may use the NovoCare $25 card. Verify on plan lookup.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with CareFirst BlueCross BlueShield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.